• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质体递送的竹红菌甲素(一种用于肿瘤治疗的潜在光敏剂)的药代动力学、组织分布及光动力治疗效果

Pharmacokinetics, tissue distribution and photodynamic therapy efficacy of liposomal-delivered hypocrellin A, a potential photosensitizer for tumor therapy.

作者信息

Wang Z J, He Y Y, Huang C G, Huang J S, Huang Y C, An J Y, Gu Y, Jiang L J

机构信息

Department of Gastrointestinology, PLA 305 Hospital, Beijing, China.

出版信息

Photochem Photobiol. 1999 Nov;70(5):773-80.

PMID:10568169
Abstract

Hypocrellin A, from Hypocrella bambusae, is a novel photosensitizer of high singlet oxygen quantum yield for photodynamic therapy (PDT). Tissue distributions were studied in tumor-bearing mice as a function of time following administration. The tumor model was S-180 sarcoma transplanted into one hind leg of male Kunming mice; hypocrellin A (HA) was delivered to the mice by intravenous injection of 5 mg/kg of body weight as a suspension either as a unilamellar liposome or in dimethyl sulfoxide (DMSO)-solubilized saline. The HA was isolated from several tissues and organs, as well as tumors and peritumoral muscles and skin. Quantitation was performed by a high-performance liquid chromatographic technique with detection that utilizes the native fluorescence of HA. Independent of the delivery system, the dye was retained in tumors at higher concentrations than in normal tissues, except for kidney, liver, lung and spleen. The dye retention in tumors was high and was vehicle dependent. For the liposomal system, the maximal accumulation in tumor and maximal ratios of dye in tumor versus peritumoral muscle and skin occurred 12 h postinjection; for the DMSO saline system, the maximal ratio occurred earlier, 6 h postadministration. Liposomal delivery improved the selective accumulation of the dye in tumor with higher maximal levels in tumor and higher ratios of tumor-to-muscle and tumor-to-skin. Levels of dye were very low or not detectable in the brain. The PDT efficacy of HA in the liposome and DMSO saline systems was determined by evaluating the tumor volume regression percent. The PDT efficacy of HA in liposomes was highest when light treatment was performed at 12 h postinjection, consistent with the highest retention of HA in tumors. Similarly, the maximal PDT efficacy in DMSO saline was attained at 6 h postinjection, the highest HA retention point in tumor. Moreover, the peak PDT efficacy of HA in liposomes was much higher than that of HA in DMSO saline and even hematoporphyrin monomethylether.

摘要

竹红菌甲素(Hypocrellin A)来源于竹红菌(Hypocrella bambusae),是一种新型的用于光动力疗法(PDT)的单线态氧量子产率高的光敏剂。研究了荷瘤小鼠给药后不同时间的组织分布情况。肿瘤模型为移植到雄性昆明小鼠一侧后腿的S-180肉瘤;通过静脉注射5 mg/kg体重的竹红菌甲素(HA)悬浮液(以单层脂质体形式或溶于二甲基亚砜(DMSO)的盐溶液形式)给药。从多个组织和器官以及肿瘤、瘤周肌肉和皮肤中分离出HA。采用利用HA天然荧光进行检测的高效液相色谱技术进行定量分析。与给药系统无关,除肾脏、肝脏、肺和脾脏外,该染料在肿瘤中的浓度高于正常组织。染料在肿瘤中的滞留量较高且与载体有关。对于脂质体系统,注射后12 h肿瘤中出现最大积累量以及染料在肿瘤与瘤周肌肉和皮肤中的最大比率;对于DMSO盐溶液系统,最大比率出现得更早,给药后6 h。脂质体给药改善了染料在肿瘤中的选择性积累,肿瘤中的最大水平更高,肿瘤与肌肉以及肿瘤与皮肤的比率更高。脑中的染料水平非常低或无法检测到。通过评估肿瘤体积缩小百分比来确定HA在脂质体和DMSO盐溶液系统中的光动力疗法疗效。当在注射后12 h进行光治疗时,HA在脂质体中的光动力疗法疗效最高,这与HA在肿瘤中的最高滞留量一致。同样,DMSO盐溶液中的最大光动力疗法疗效在注射后6 h达到,这是肿瘤中HA滞留的最高时间点。此外,HA在脂质体中的光动力疗法疗效峰值远高于HA在DMSO盐溶液中的疗效峰值,甚至高于血卟啉单甲醚。

相似文献

1
Pharmacokinetics, tissue distribution and photodynamic therapy efficacy of liposomal-delivered hypocrellin A, a potential photosensitizer for tumor therapy.脂质体递送的竹红菌甲素(一种用于肿瘤治疗的潜在光敏剂)的药代动力学、组织分布及光动力治疗效果
Photochem Photobiol. 1999 Nov;70(5):773-80.
2
Effect of delivery system on the pharmacokinetics and tissue distribution of bis(di-isobutyl octadecylsiloxy)silicon 2,3-naphthalocyanine (isoBOSINC), a photosensitizer for tumor therapy.递送系统对双(二异丁基十八烷基硅氧基)硅2,3-萘酞菁(isoBOSINC,一种用于肿瘤治疗的光敏剂)的药代动力学和组织分布的影响。
Photochem Photobiol. 1996 Jan;63(1):132-40. doi: 10.1111/j.1751-1097.1996.tb03004.x.
3
Evaluation of Hypocrellin B in a human bladder tumor model in experimental photodynamic therapy: biodistribution, light dose and drug-light interval effects.竹红菌乙素在人膀胱肿瘤实验性光动力治疗模型中的评估:生物分布、光剂量及药物 - 光间隔效应
Int J Oncol. 2004 Sep;25(3):623-9.
4
Liposomal hypocrellin B as a potential photosensitizer for age-related macular degeneration: pharmacokinetics, photodynamic efficacy, and skin phototoxicity in vivo.脂质体竹红菌素B作为年龄相关性黄斑变性的潜在光敏剂:体内药代动力学、光动力疗效及皮肤光毒性
Photochem Photobiol Sci. 2015 May;14(5):972-81. doi: 10.1039/c4pp00412d.
5
Enhanced effect of photodynamic therapy in ovarian cancer using a nanoparticle drug delivery system.使用纳米颗粒药物递送系统增强光动力疗法对卵巢癌的治疗效果。
Int J Oncol. 2015 Sep;47(3):1070-6. doi: 10.3892/ijo.2015.3079. Epub 2015 Jul 10.
6
Efficacy of hypocrellin pharmacokinetics in phototherapy.竹红菌素光动力学疗法的疗效
Int J Oncol. 2002 Dec;21(6):1229-37.
7
In vitro and in vivo antitumor activity of a novel hypocrellin B derivative for photodynamic therapy.新型竹红菌素 B 衍生物用于光动力疗法的体外和体内抗肿瘤活性。
Photodiagnosis Photodyn Ther. 2014 Jun;11(2):204-12. doi: 10.1016/j.pdpdt.2014.01.003. Epub 2014 Feb 14.
8
Lipophilic photosensitizer administration via the prostate arteries for photodynamic therapy of the canine prostate.经前列腺动脉给予亲脂性光敏剂行光动力疗法治疗犬前列腺。
Photodiagnosis Photodyn Ther. 2010 Jun;7(2):106-14. doi: 10.1016/j.pdpdt.2010.03.003. Epub 2010 Apr 24.
9
Photodynamic therapy induced Fas-mediated apoptosis in human carcinoma cells.光动力疗法诱导人癌细胞中Fas介导的细胞凋亡。
Int J Mol Med. 2002 Mar;9(3):257-70.
10
Photocytotoxicity of hypocrellin B (HB) was enhanced by liposomalization in vitro.HB 的光细胞毒性在体外通过脂质体化得到增强。
Int J Toxicol. 2011 Mar;30(2):174-80. doi: 10.1177/1091581810394548.

引用本文的文献

1
Overcoming Barriers in Photodynamic Therapy Harnessing Nanogenerators Strategies.克服光动力治疗中的障碍——利用纳米发电机策略。
Int J Biol Sci. 2024 Oct 14;20(14):5673-5694. doi: 10.7150/ijbs.100317. eCollection 2024.
2
Spotlight on Photoactivatable Liposomes beyond Drug Delivery: An Enabler of Multitargeting of Molecular Pathways.聚焦光激活脂质体在药物传递之外的应用:分子途径多靶点靶向的实现者。
Bioconjug Chem. 2022 Nov 16;33(11):2041-2064. doi: 10.1021/acs.bioconjchem.2c00376. Epub 2022 Oct 5.
3
Multifunctional Nanoplatforms as a Novel Effective Approach in Photodynamic Therapy and Chemotherapy, to Overcome Multidrug Resistance in Cancer.
多功能纳米平台作为光动力疗法和化疗中克服癌症多药耐药性的一种新型有效方法。
Pharmaceutics. 2022 May 17;14(5):1075. doi: 10.3390/pharmaceutics14051075.
4
Mechanisms for Tuning Engineered Nanomaterials to Enhance Radiation Therapy of Cancer.调节工程纳米材料以增强癌症放射治疗的机制。
Adv Sci (Weinh). 2020 Oct 28;7(24):2003584. doi: 10.1002/advs.202003584. eCollection 2020 Dec.
5
Enhanced Production and Anticancer Properties of Photoactivated Perylenequinones.光激活苝醌类化合物的增强生产和抗癌性能。
J Nat Prod. 2020 Aug 28;83(8):2490-2500. doi: 10.1021/acs.jnatprod.0c00492. Epub 2020 Aug 10.
6
Antifungal activity of hypocrellin compounds and their synergistic effects with antimicrobial agents against Candida albicans.竹红菌素化合物的抗真菌活性及其与抗微生物药物对白色念珠菌的协同作用。
Microb Biotechnol. 2021 Mar;14(2):430-443. doi: 10.1111/1751-7915.13601. Epub 2020 Jun 8.
7
Liposomal formulations of photosensitizers.脂质体剂型的光敏剂。
Biomaterials. 2019 Oct;218:119341. doi: 10.1016/j.biomaterials.2019.119341. Epub 2019 Jul 10.
8
Photonanomedicine: a convergence of photodynamic therapy and nanotechnology.光纳米医学:光动力疗法与纳米技术的融合。
Nanoscale. 2016 Jul 7;8(25):12471-503. doi: 10.1039/c5nr08691d. Epub 2016 Jun 20.
9
Drug Carrier for Photodynamic Cancer Therapy.用于光动力癌症治疗的药物载体
Int J Mol Sci. 2015 Sep 14;16(9):22094-136. doi: 10.3390/ijms160922094.
10
Can nanotechnology potentiate photodynamic therapy?纳米技术能增强光动力疗法吗?
Nanotechnol Rev. 2012 Mar;1(2):111-146. doi: 10.1515/ntrev-2011-0005.